Taiwan Barry Lam, founder and chairman of Quanta Computer, shares the story of how he built the company into one of the world’s leading electronics and IT manufacturers. Lam then sheds light on Quanta’s expansion into healthcare and his strategy to position the firm as an AI tool provider, helping to…
Opinion Krishna Cheriath, chief data officer at BMS, outlines the ways in which AI is already transforming the delivery of healthcare, what modern biopharma companies’ AI innovation agendas should include, and why behavioural change is a key tenet in securing meaningful health outcomes with AI. As Biopharma increases AI investments,…
Canada Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to driving change at a much larger level via a ‘collective impact’ approach. When I encountered the concept of collective impact in the Stanford Social Innovation Review, I realized the possibilities lay…
Thailand Dr Tares Krassanairawiwong, secretary-general of the Thai FDA shares the recent reforms carried out in the hope of facilitating greater patient access to both domestic and internationally-produced treatments. Dr Krassanairawiwong also highlights the institution’s current priorities, including medical cannabis, positioning Thailand as a clinical trials hub, and further developing the…
Opinion Janssen Australia & New Zealand’s Bruce Goodwin argues that greater adoption of patient-centric practices is beneficial to patients, companies and healthcare systems as a whole. Goodwin also gives his five fundamental pillars to adopting a patient-centric approach. We know that patient-centricity not only aids better healthcare, it also has…
China Jim Xu, GM of Medidata China, shares the importance of the China market to Medidata Solutions, the global leader in cloud services and solutions to the life sciences industry; his three priorities to foster stronger customer relationships, build talent, and deliver our offerings locally to the China market; as well…
Taiwan Dr Chien-Huang Lin, tenth president of Taipei Medical University, shares his personal mission upon taking the role, elaborates on the research strengths of TMU, and goes on to discuss the university’s unique commitment to translational research, innovation collaboration, and talent development. The cancer space is very large, and we…
Puerto Rico Dr David Lenihan, president of Ponce Health Sciences University (PHSU) in Puerto Rico, highlights the crucial role the institution plays in tackling the cultural deficit in healthcare on the US mainland as the Hispanic population increases. Lenihan also touches on how Puerto Rico can help counter the shortage of physicians…
Lithuania With the end of the Lithuanian Parliament’s Spring Session, a period of neverending discussions and misunderstandings has ended too, as the Parliament and the Ministry of Health have finally adopted a new medicines reimbursement system, writes Ruta Pumputienė. Lithuanian Ministry of Health deserves compliments for getting involved in the…
Opinion Much has been made of how Big Pharma needs to learn from Big Tech in order to fully adapt to the digital age. Here, pharma industry veteran Richard Bergström argues that, in fact, the technology industry has much to learn from the pharmaceutical industry and that biopharma is well-placed to…
Sanofi Pius Hornstein, Country Chair of Sanofi China appointed in March 2019, shares his initial impressions on the fast-changing Chinese market; his mandate to drive a transformation of the organization in line with their mid- to long-term strategy; his priorities of launching a new portfolio, building up the organization, and spearheading…
Biotech Dr Dean Tsao, chairman and CEO of PlexBio Co., Ltd., shares the story of his impressive expert background which led him to form the in vitro diagnostics (IVD) company in 2010. Dr. Tsao goes on to explain the company’s unique multiplexing technology based on the πCode™ MicroDisc (‘pi-Code MicroDiscs’), and…
See our Cookie Privacy Policy Here